News‎ > ‎News archive‎ > ‎

Dr. Riccardo Saccardi appointed as new JACIE Medical Director

posted 14 Dec 2015, 08:52 by Eoin McGrath   [ updated 31 May 2016, 01:55 ]
The EBMT is pleased to announce the appointment of Dr. Riccardo Saccardi as the new JACIE Medical Director. Dr. Saccardi will take over from Prof. John Snowden with effect from 1 January 2016. The appointment follows an open recruitment process launched in October which led to three candidates being shortlisted for interview. The high quality of all of the candidates made the decision very difficult and we are grateful to everyone who participated.

Dr. Saccardi has been involved in the field of Haematopoietic Stem Cell Transplantation since his specialization in Haematology and has worked in the clinical, laboratory and cord blood bank areas. His centre has successfully implemented both the ISO and FACT-JACIE Standards. 

In 2003, he participated in one of the first JACIE inspector training courses and since then has regularly participated in JACIE inspections, mostly in clinical facilities and often as team leader. He also regularly attends the annual courses organized by the Italian Transplant Agency (CNT) for training inspectors for the national accreditation program, based on the JACIE standards.

In addition to day-to-day haemato-oncology and HSCT practice, his main academic interest has been severe autoimmune diseases and he has led and contributed to various national and international networks, both in the clinic and in the lab including cooperative studies for the standardization of graft quality both in cord blood and peripheral blood stem cells. In this way, Dr Saccardi is not only well positioned to advise on routine aspects of HSCT, but also his expertise will help develop JACIE’s perspective of new cellular therapies.

He firmly believes that rules and regulations in all fields of clinical medicine must continuously evolve, updating clinical practice from experimental medicine and promoting standardization across countries. He considers that JACIE has been a very important tool to both increase the safety of procedures and promote the homogenization of clinical practice of HSCT in Europe and further afield. He also believes that the development and management of regulations must be carried out through close interaction between quality management specialists and clinical professionals involved in daily practice, keeping the standards as close as possible to the field of transplantation.

We look forward to supporting Dr. Saccardi in his new role and to bringing his experience and knowledge to bear on the continuous improvement of the Standards and the accreditation process for the benefit of patients, donors and transplant professionals.

Selected membership and participation
  • Member of EBMT (CIC 304)
  • Member of the Board of the Italian HSCT Society (GITMO)
  • Coordinator of the GITMO Cell Processing section
  • Member of Italian Health Authority Committee for the implementation of the Unique Identification Code System of Tissues and Cells for Human Application
  • Member of the Working Group (WG) promoted by the European Directorate for the Quality of Medicines and Healthcare (EDQM) preparing the 3rd edition of the Guide to the Quality and Safety of Tissues and Cells for Human Application.
  • Dr. Saccardi was a member of the EBMT Board for 8 years which gave him both an insight into the Society and an overview of HSCT across Europe. 
Dr. Saccardi is based at the Azienda Ospedaliero Universitaria Careggi Largo Brambilla n° 3 – 50134 Firenze, Italy
Comments